People news

Share this article:
GlaxoSmithKline has appointed Dan Troy as SVP and general council. Troy will join the company on September 2, 2008. Troy is currently a partner at Washington law firm Sidley Austin, LLP. He was formerly a chief counsel for the FDA.

Human Genome Sciences has appointed David Southwell to its board of directors. Southwell previously worked at Sepracor, where he served as EVP, chief financial officer.

Biogen Idec has named Brian Posner to its board of directors. Posner was formerly employed as CEO and co-chief investment officer at ClearBridge Advisors LLC, a division of Legg Mason Inc., an asset management company.

Inventiv's Selva Group named Lynne Marie Denis event supervisor. Denis joins Selva from the Society of Obstetricians and Gynaecologists of Canada, where she was events and conference manager. 

Concentric Pharma Advertising named Robin Goodrich strategic planner. Goodrich joins from the Princeton office of German marketing consultancy Metaplan. 
Share this article:
You must be a registered member of MMM to post a comment.

Next Article in People Moves

Email Newsletters

MM&M Future Leaders

Register now

Early bird $1,950 before 31 October 2014

*Group discounts available on request 


Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in People Moves

Monday Moves: October 20

Promotions and hires for agencies and manufacturers

Monday Moves: September 29

Promotions and hires for agencies and manufacturers

Monday Moves—July 21, 2014

Hires and promotions for Manufacturers, Agencies and Media